ProPhase Labs, Inc. (NAS: PRPH) Stock Analysis & Fundamentals | ScreenerHero

Create free account

PRPHProPhase Labs, Inc.

NAS · US · Healthcare · Diagnostics & Research · prophaselabs.com

0.0620USD+2.99%Mkt Cap: 869004 $P/E: —1d ago

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a ra…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.85BUSDP/E 44.2

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.06BUSDP/E 27.3

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 21.6

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.75BUSDP/E 26.5

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.64BUSDP/E 41.7

Personalis, Inc.

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Clínica Baviera, S.A.

$1.02BUSDP/E 21.4

OPKO Health, Inc.

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$293.12MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Prostatype Genomics AB (publ)

Telo Genomics Corp.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap869.00K $

Enterprise Value9.72M $

Revenue (TTM)3.39M $

Gross Profit1.38M $

Net Income (TTM)-14.74M $

Revenue/Share0.3170 USD

Last Price0.0620 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees19

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)0.13

PEG—

EV/EBITDA-0.77

EV/Revenue2.87

P/S0.26

P/B-1.41

EPS (TTM)-1.85

EPS (Forward)0.48

52W Range

0.05980% of range6.700

52W High6.700 USD

52W Low0.0598 USD

Profitability

Gross Margin31.85%

Oper. Margin-544.98%

EBITDA Margin0.00%

Profit Margin-339.31%

ROE-420.27%

ROA-24.62%

Growth

Revenue Growth-66.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF-8.34M $

CapEx (TTM)—

FCF Margin1400.26%

FCF Yield5465.65%

Net Debt8.88M $

Net Debt/EBITDA-0.70

Balance Sheet

Debt/Equity2.46

Current Ratio0.06

Quick Ratio0.03

Book Value/Sh-0.0440 USD

Cash/Share0.0020 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay DateJun 3, 2022

Splits

Last Split1:10

Split DateDec 22, 2025

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.14.02M

Float13.68M

Insiders2.37%

Institutions0.07%

Short Interest

Short Ratio0.1d

Short % Float0.71%

Short % Out.0.65%

Shares Short30.02K

Short (prev mo.)8.96K

Technical

SMA 500.1010 (-38.6%)

SMA 2001.056 (-94.1%)

Beta0.07

S&P 52W Chg20.25%

Avg Vol (30d)50.92K

Avg Vol (10d)192.71K

Technical Indicators

RSI (14)34.3

MACD-0.0103

MACD Signal-0.0092

MACD Hist.-0.0012

BB Upper0.0960 USD

BB Middle0.0770 USD

BB Lower0.0581 USD

BB Width49.18%

ATR (14)0.0124 USD

Vol Ratio (20d)0.12x